EMEA-002430-PIP01-18

Key facts

Active substance
Timrepigene emparvovec
Therapeutic area
Ophthalmology
Decision number
P/0085/2020
PIP number
EMEA-002430-PIP01-18
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Treatment of choroideremia
Route(s) of administration
Ophthalmic use
Contact for public enquiries
Nightstar Europa Limited

E-mail: enquiries@nightstartx.com
Tel.:  +44 1628512604

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating